[Webinar] NS Pharma's Exon 53 Skipping Program - November 2016
Like 1 Dislike 0 Published on 22 Nov 2016
On November 16, 2016, Parent Project Muscular Dystrophy and NS Pharma (US subsidiary of Nippon Shinyaku, Co.,Ltd) hosted a webinar to discuss NS Pharma's Exon 53 Skipping Program. Dr. Clemens and Lauren Morgenroth reviewed data from the Phase I study conducted in Japan and presented the study design for the trial that is opening in the US later this month.